Literature DB >> 33715001

Retinal microcirculation abnormalities in patients with systemic sclerosis: an explorative optical coherence tomography angiography study.

Adriano Carnevali1, Giuseppe Giannaccare1, Valentina Gatti1, Caterina Battaglia1, Giorgio Randazzo1, Angeli Christy Yu2, Marco Pellegrini3, Francesco Ferragina1, Mario Damiano Toro4,5, Caterina Bruno6, Vincenzo Scorcia1, Francesco Ursini7,8.   

Abstract

OBJECTIVES: To investigate subclinical and clinical abnormalities in retinal and choroidal vascular plexuses in patients with SSc by means of optical coherence tomography angiography (OCT-A).
METHODS: A total of 20 consecutive SSc patients were recruited and compared with 20 healthy subjects. Quantitative analysis of vessel density (VD), choriocapillaris plexus flow index (CCP-FI) and choroidal vascularity index were performed on OCT-A images in the superficial capillary plexus (SCP), deep capillary plexus (DCP) and CCP for all patients. Images were further reviewed by two independent readers for the assessment of qualitative abnormalities, including tortuosity, rarefaction areas, megacapillaries and macular-foveal capillaries.
RESULTS: The DCP-VD in the whole scan and in the perifoveal, superior, inferior, nasal and temporal regions was significantly lower in the SSc group. The CCP-FI was significantly higher in SSc patients. When comparing SSc patients with and without digital ulcers, significantly decreased SCP-VD was demonstrated in the whole, perifoveal, superior, inferior, temporal and nasal regions. No difference in any of the OCT-A parameters was observed when comparing patients with and without interstitial lung disease. Qualitative analysis of OCT-A revealed at least one abnormality in 95% of patients.
CONCLUSION: We showed the ability of OCT-A to disclose early ocular vascular abnormalities in patients with SSc. Our results may represent a hypothesis-generating basis for exploring the potential role of OCT-A in diagnosis, monitoring and prognosis stratification in SSc.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  megacapillary; optical coherence tomography angiography; systemic sclerosis; vessel density

Mesh:

Year:  2021        PMID: 33715001     DOI: 10.1093/rheumatology/keab258

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  5 in total

1.  Biomarkers for Nonexudative Age-Related Macular Degeneration and Relevance for Clinical Trials: A Systematic Review.

Authors:  Vivienne Fang; Maria Gomez-Caraballo; Eleonora M Lad
Journal:  Mol Diagn Ther       Date:  2021-08-25       Impact factor: 4.074

2.  Recombinant Human Nerve Growth Factor (Cenegermin)-Driven Corneal Wound Healing Process: An Evidence-Based Analysis.

Authors:  Chiara Bonzano; Sara Olivari; Carlo Alberto Cutolo; Angelo Macrì; Daniele Sindaco; Davide Borroni; Elisabetta Bonzano; Carlo Enrico Traverso
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

3.  Altered ocular microvasculature in patients with systemic sclerosis and very early disease of systemic sclerosis using optical coherence tomography angiography.

Authors:  Nataša Mihailovic; Larissa Lahme; Sonja Braasch; Friederike Rosenberger; Nicole Eter; Jan Ehrchen; Maged Alnawaiseh
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

4.  Acute and subacute macular and peripapillary angiographic changes in choroidal and retinal blood flow post-intravitreal injections.

Authors:  Nadhini Arumuganathan; Maximilian Robert Justus Wiest; Mario Damiano Toro; Timothy Hamann; Katrin Fasler; Sandrine Anne Zweifel
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

Review 5.  Ocular Manifestations of Buerger's Disease - A Review of Current Knowledge.

Authors:  Urszula Szydełko-Paśko; Joanna Przeździecka-Dołyk; Rafał Małecki; Andrzej Szuba; Marta Misiuk-Hojło
Journal:  Clin Ophthalmol       Date:  2022-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.